Ameritas Investment Partners, Inc. Nex Immune, Inc. Transaction History

Ameritas Investment Partners, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $2,178 - $6,332	-1,353 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $8,586 - $14,060	832 Added 159.69%	1,353 $20,000
Q1 2021 May 14, 2021	BUY	$17.95 - $25.91 $9,351 - $13,499	521 New	521 $10,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.